Myriad Genetics Submits First Module of Premarket Approval Application to FDA for myChoice® HRD CDx Test
New Studies Highlight Performance of Vectra Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
Landmark Study Shows GeneSight Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder
Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery